The third transmembrane domains of the human B1 and B2 bradykinin receptor subtypes are involved in discriminating between subtype-selective ligands

被引：0
|
作者：
Fathy, DB [1 ]
Mathis, SA [1 ]
Leeb, T [1 ]
Leeb-Lundberg, LMF [1 ]
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2751
引用
收藏
页码：A1328 / A1328
页数：1
相关论文
共 50 条
  • [1] The sixth transmembrane domains of the human B1 and B2 bradykinin receptors are structurally compatible and involved in discriminating between subtype-selective agonists
    Leeb, T
    Mathis, SA
    LeebLundberg, LMF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (01) : 311 - 317
  • [2] A single position in the third transmembrane domains of the human B1 and B2 bradykinin receptors is adjacent to and discriminates between the C-terminal residues of subtype-selective ligands
    Fathy, DB
    Mathis, SA
    Leeb, T
    Leeb-Lundberg, LMF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) : 12210 - 12218
  • [3] THE ROLE OF THE CHOLECYSTOKININ-B GASTRIN RECEPTOR TRANSMEMBRANE DOMAINS IN DETERMINING AFFINITY FOR SUBTYPE-SELECTIVE LIGANDS
    KOPIN, AS
    MCBRIDE, EW
    QUINN, SM
    KOLAKOWSKI, LF
    BEINBORN, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) : 5019 - 5023
  • [4] Synthesis and biological evaluation of bradykinin B1/B2 and selective B1 receptor antagonists
    Amblard, M
    Bedos, P
    Olivier, C
    Daffx, I
    Luccarini, JM
    Dodey, P
    Pruneau, D
    Paquet, JL
    Martinez, J
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (12) : 2382 - 2386
  • [5] From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists
    Barth, Martine
    Bondoux, Michel
    Luccarini, Jean-Michel
    Peyrou, Vincent
    Dodey, Pierre
    Pruneau, Didier
    Massardier, Christine
    Paquet, Jean-Luc
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (06) : 2574 - 2584
  • [6] Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists
    Landgraf, RG
    Sirois, P
    Jancar, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 460 (01) : 75 - 83
  • [7] Retinal Bradykinin B1 and B2 Receptor Signaling and Action in Diabetes
    Kita, T.
    Clermont, A.
    Aiello, L. P.
    Feener, E. P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [8] Sensitization to bradykinin B1 and B2 receptor activation in UV-B irradiated human skin
    Eisenbarth, H
    Rukwied, R
    Petersen, M
    Schmelz, M
    PAIN, 2004, 110 (1-2) : 197 - 204
  • [9] Functional characterization of bradykinin analogues on recombinant human bradykinin B1 and B2 receptors
    Simpson, PB
    Woollacott, AJ
    Hill, RG
    Seabrook, GR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 392 (1-2) : 1 - 9
  • [10] Induction of B1 bradykinin receptors with lipopolysaccharide treatment in B2 bradykinin receptor knockout mice
    Shepheard, SL
    Cook, DA
    Hargreaves, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126
12345